Oncology
5,311 studies490 in 7 days2,547 in 30 days
Filters
Latest
5,311 studies
- Lung adenocarcinoma with rapid progression and fatal outcome through spread through air spaces: an autopsy case report.
- Genomic characteristics, survival, and prognostic analysis of advanced non-small cell lung cancer with KRAS mutations and brain metastases.
- Quantitative CT definition of solid components in pulmonary ground-glass nodules: a pixel-level annotation-based development and internal validation study.
- Machine-learning-assisted multi-omics profiling identifies CALB1 as a subtype-associated regulator of PI3K/AKT signaling and malignant progression in non-small cell lung cancer.
- Single cell imaging mass spectrometry spatial immune profiling of brain metastasis from non-small-cell lung cancer patients treated with immune checkpoint inhibitors.
- Development and internal validation of a nomogram for predicting short- and long-term overall survival in patients with breast cancer liver metastasis: a SEER-based prognostic study
- Association of the glucose-to-lymphocyte ratio with short-term mortality in critically ill patients with documented mitral valve disease: A retrospective cohort study
- Burden, trends, and projections of prostate cancer: global cancer statistics (GLOBOCAN) estimates for 2024 and 2022
- A multi-omics analysis of advanced triple-negative breast cancer identifies predictors to chemo-immunotherapy and on-treatment dynamics
- Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type, With Rapid Systemic Progression in an Elderly Patient: A Case Report
- Chronic Myeloid Leukemia Progressing to Early T-Cell Precursor Lymphoblastic Blast Phase Following Treatment Default: An Integrated Morphologic, Immunophenotypic, Cytogenetic, and Molecular Case Report
- Combined celecoxib and NDGA induces a non-canonical, autophagy-independent redox cell death via p62/KEAP1 in colorectal cancer
- A Novel ACLY Inhibitor Induces Transcriptional and Metabolic Reprogramming to Overcome Tyrosine kinase inhibitor Resistance in Lymphoma
- The Smac mimetic drug Xevinapant sensitizes triple negative breast cancer to radiotherapy-induced cell death in a TNFα dependent manner
- Targeting REV7 exposes a mitotic vulnerability in colorectal cancer cells
- Cell-of-origin shapes tumor subtype in BRCA1-associated triple-negative breast cancer
- Tumor suppressor-like mutations mark a dosage-constrained dependency in leukemia
- Fractional Order Temporal Dynamics of Tumor Immune Chemotherapy Interactions: A Reproducible Dimensionless Analysis and a Pharmacokinetic Caveat
- Novel Replication Stress-Associated High-Grade Serous Ovarian Cancer Models Recapitulate Diverse Tumour Ecosystems and Enable Preclinical Studies
- Dual inhibition of p38α MAPK and Casein kinase δ/ϵ as a novel treatment strategy for AR-independent and taxane-resistant advanced prostate cancer
- Endothelial AMBRA1 loss contributes to vascular dysregulation facilitating metastatic progression in early-stage melanoma
- RNA splicing factor mutations drive myeloid neoplasm oncogenesis through protein complex poisoning
- BRCA2 loss drives a PKM1-dominant glycolytic state that is selectively lethal to pyruvate kinase activation
- A Saturated Aminotriester Lipid Enhances Amonafide Activity in Human Colorectal Cancer Cells
- FHL1 Downregulation Is Specific to Cancer-Associated Fibroblasts and Linked to Reduced Chromatin Accessibility in Colorectal Cancer.